| Product Code: ETC8615301 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Despite a decrease in growth rate in 2024, the import shipments of therapeutic vaccines to Niger continue to be dominated by top exporters China, France, India, Benin, and Ghana. The high concentration of the Herfindahl-Hirschman Index (HHI) signifies a strong market share among these countries, with a notable increase from 2023 to 2024. With a remarkable compound annual growth rate (CAGR) of 26.19% from 2020 to 2024, the therapeutic vaccines market in Niger demonstrates promising expansion potential amidst evolving dynamics in the global healthcare landscape.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Niger Therapeutic Vaccines Market Overview |
3.1 Niger Country Macro Economic Indicators |
3.2 Niger Therapeutic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Niger Therapeutic Vaccines Market - Industry Life Cycle |
3.4 Niger Therapeutic Vaccines Market - Porter's Five Forces |
3.5 Niger Therapeutic Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Niger Therapeutic Vaccines Market Revenues & Volume Share, By Therapeutic Vaccines, 2021 & 2031F |
4 Niger Therapeutic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing awareness about preventive healthcare measures |
4.2.2 Increasing prevalence of infectious diseases in Niger |
4.2.3 Supportive government initiatives for immunization programs |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in remote areas |
4.3.2 High cost associated with vaccine development and distribution |
4.3.3 Lack of proper infrastructure for vaccine storage and distribution |
5 Niger Therapeutic Vaccines Market Trends |
6 Niger Therapeutic Vaccines Market, By Types |
6.1 Niger Therapeutic Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Niger Therapeutic Vaccines Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Niger Therapeutic Vaccines Market Revenues & Volume, By Peptide Therapeutic Vaccine, 2021- 2031F |
6.1.4 Niger Therapeutic Vaccines Market Revenues & Volume, By Cell Therapeutic Vaccine, 2021- 2031F |
6.1.5 Niger Therapeutic Vaccines Market Revenues & Volume, By Nucleic Acid Therapeutic Vaccine, 2021- 2031F |
6.2 Niger Therapeutic Vaccines Market, By Therapeutic Vaccines |
6.2.1 Overview and Analysis |
6.2.2 Niger Therapeutic Vaccines Market Revenues & Volume, By Oncotherapy, 2021- 2031F |
6.2.3 Niger Therapeutic Vaccines Market Revenues & Volume, By Hepatitis B, 2021- 2031F |
6.2.4 Niger Therapeutic Vaccines Market Revenues & Volume, By Tuberculosis, 2021- 2031F |
6.2.5 Niger Therapeutic Vaccines Market Revenues & Volume, By Herpes Simplex Virus, 2021- 2031F |
6.2.6 Niger Therapeutic Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
7 Niger Therapeutic Vaccines Market Import-Export Trade Statistics |
7.1 Niger Therapeutic Vaccines Market Export to Major Countries |
7.2 Niger Therapeutic Vaccines Market Imports from Major Countries |
8 Niger Therapeutic Vaccines Market Key Performance Indicators |
8.1 Rate of vaccination coverage in target population groups |
8.2 Number of new vaccine candidates in the pipeline for diseases prevalent in Niger |
8.3 Percentage of healthcare facilities equipped with cold chain storage facilities for vaccines |
9 Niger Therapeutic Vaccines Market - Opportunity Assessment |
9.1 Niger Therapeutic Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Niger Therapeutic Vaccines Market Opportunity Assessment, By Therapeutic Vaccines, 2021 & 2031F |
10 Niger Therapeutic Vaccines Market - Competitive Landscape |
10.1 Niger Therapeutic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Niger Therapeutic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |